Skip to main content
John Carey, MD, Otolaryngology (ENT), Baltimore, MD, Johns Hopkins Hospital

JohnPatrickCareyMD

Otolaryngology (ENT) Baltimore, MD

Neurotology

Professor of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine; Chief, Division of Otology, Neurotology and Skull Base Surgery, Professor of Otolaryngology-Head and Neck Surgery, Director, Neurotology Fellowship Program

Dr. Carey is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Carey's full profile

Already have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Neurotology, 1998 - 2000
  • University of Washington
    University of WashingtonResidency, Otolaryngology - Head and Neck Surgery, 1993 - 1998
  • Virginia Mason Franciscan Health
    Virginia Mason Franciscan HealthResidency, Surgery, 1991 - 1993
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 1991

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1999 - 2024
  • NC State Medical License
    NC State Medical License 2020 - 2022
  • OH State Medical License
    OH State Medical License 1995 - 2015
  • WA State Medical License
    WA State Medical License 1993 - 1998
  • American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
  • American Board of Otolaryngology - Head and Neck Surgery Neurotology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Fellow (FAAO-HNS) American Academy of Otolaryngology - Head and Neck Surgery

Clinical Trials

Publications & Presentations

PubMed

Grant Support

  • A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2 Study of Oto-104 Given as a Single Intratympanic Injection in Subjects with Unilateral Meniere’s DiseaseOtonomy2014–Present
  • A Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Study of the Safety and Efficacy of Two Fixed Doses of PF-04958242 in Subjects with Age-Related Sensorineural Hearing LossPfizer2012–2013
  • Evaluation of Vestibular Function in Ménière’s DiseaseNIH-NIDCD2005–2011
  • Intratympanic Steroids for Sudden Hearing LossNIH-NIDCD2004–2010
  • Effects of Low-Dose Gentamicin on Labyrinthine StructureAmerican Otological Society2005–2006
  • Vestibular Recovery after Intratympanic GentamicinNIH-NIDCD2002–2005
  • Vestibular Effects of Intratympanic GentamicinNIH-NIDCD2000–2005
  • Vestibular Effects of Intratympanic GentamicinJohns Hopkins2001–2003
  • Acoustic Responses of Vestibular Afferents: Implications for the Superior Canal Dehiscence SyndromeAmerican Hearing Research Foundation1999–2000

Professional Memberships

Other Languages

  • German, Russian

Hospital Affiliations